SIMPLE Chemotherapy for NK Lymphoma/Leukaemia
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)"
- Status
- COMPLETED
- Phase
- PHASE2
PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
- Status
- COMPLETED
- Phase
- PHASE3
Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Herzuma-capecitabine/Cisplatin for Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
- Status
- RECRUITING
- Phase
- PHASE3
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Apatinib in Neoadjuvant Therapy for Patients With Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase II Umbrella Study Directed by Next Generation Sequencing
- Status
- UNKNOWN
- Phase
- PHASE2
Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001)
- Status
- COMPLETED
- Phase
- PHASE1
A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer
- Status
- UNKNOWN
- Phase
- NA